Detalhe da pesquisa
1.
Safety outcomes of selective serotonin reuptake inhibitors in adolescent attention-deficit/hyperactivity disorder with comorbid depression: the ASSURE study.
Psychol Med
; 53(10): 4811-4819, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-36803587
2.
Safety Outcomes of Selective Serotonin Reuptake Inhibitors in Adolescent Attention-Deficit/Hyperactivity Disorder with Comorbid Depression: The ASSURE Study - CORRIGENDUM.
Psychol Med
; 53(10): 4831, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37078398
3.
Long-term methylphenidate use for children and adolescents with attention deficit hyperactivity disorder and risk for depression, conduct disorder, and psychotic disorder: a nationwide longitudinal cohort study in South Korea.
Child Adolesc Psychiatry Ment Health
; 16(1): 80, 2022 Oct 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-36221129